GLP-1 Receptor Agonist Market on the Rise with Anticipated Surge to $16.82 Billion by 2028
January 29, 2024 10:48 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "GLP-1 Receptor Agonist Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global market for GLP-1 receptor...
ProLynx and Daiichi Sankyo announce the development of technology for half-life extension of small molecules in the eye
August 29, 2018 09:00 ET
|
ProLynx LLC
SAN FRANCISCO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- ProLynx and Daiichi Sankyo Company, Limited, announced today the publication of a paper in the journal TVST entitled “A controlled release system for...
ProLynx extends lead in half-life extension platform technology – Shows primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system
April 03, 2018 09:00 ET
|
ProLynx LLC
SAN FRANCISCO, April 03, 2018 (GLOBE NEWSWIRE) -- ProLynx announced today the publication of a paper demonstrating its leading capabilities to exploit primary deuterium kinetic isotope effects...
ProLynx announces SBIR grant award to develop novel technology for dual receptor agonists
September 25, 2017 09:00 ET
|
ProLynx LLC
SAN FRANCISCO, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Today, ProLynx announced it was awarded a Small Business Innovation Research (SBIR) grant from the NIH to expand its technology platform to control...